Innovation & Research

A depiction of a bloodstream and a virus
The National Institutes of Health has selected Pitt to lead a trio of Phase 3 clinical trials involving COVID-19 patients that will explore the use of blood thinners in saving lives and improving care.
A person in a green sweater
Social work graduate student Ashlé Hall (SOC WK ’18) is a busy entrepreneur with a new line of hair care products designed to fill two very important needs.
A depiction of cells in purple and blue
The Human BioMolecular Atlas Program is developing an open, global platform to map healthy cells so doctors, scientists and educators can better understand disease and the workings of the human body.
a blue-scrubbed person putting an intubation device into a clear box with a mannequin inside
Intubating COVID-19 patients can be dangerous for the health care provider. A new biocontainment unit developed by a Pitt-UPMC team trapped more than 99.99% of simulated virus-sized aerosols and prevented them from escaping into the environment
A person in a black top and necklace
A study led by pathology’s Samira Kiani and published today in Nature Cell Biology showed that a new approach to CRISPR briefly suppressed genes to control the immune response in mice, making gene therapy delivery more effective.
Angus in a blue suit
Published as part of a four-article package today in JAMA, research led by Pitt’s Derek Angus found that an inexpensive treatment of steroids can substantially improve survival in critically ill COVID-19 patients. The findings, part of a multi-site global trial, were so stark that the World Health Organization is updating its treatment guidance for the disease.
A woman in an orange shirt leaning against a brick wall
While Pennsylvania was in the midst of COVID-19 shelter-in-place orders, Pitt senior Gina Watkins was digging into the reasoning behind past quarantine measures—finding racism and xenophobia were major players in policy decisions.
triangle chips that look like Doritos spread out on a blue background
Should dieters worry about portion sizes or “light” versions of a snack? Assistant Professor Peggy Liu led a series of studies to find out.
an image of the coronavirus
Virologist Megan Culler Freeman has been curious about reinfections since the pandemic began. For The Conversation, she addressed some questions raised by a man who reportedly was reinfected with SARS-CoV-2.
An electronic device hanging by a clip with a swimmer with a Pitt cap on in the background
From swimming devices to rare disease gene therapies, Pitt inventors never stop: The Innovation Institute reported a record 394 invention disclosures for last fiscal year, and Director Evan Facher says another robust year is ahead.